a get for X. on and that on as charts are reinforce Thanks Mick, on I Thanks, me I'll really through comment good And that you morning, web. them.Let begin interesting, there you'll to the find up are joining to would There today. us couple everyone. we I Slide what and the refer Mick think said, on
our saying our going I'll right about Michael to the quarter a call you Stratasys want takeaways performance -- I wrap of year update taking our provide the with X now. to want then engagement in comments what's today's by before up on with and that And the by CFO, the morning for happening back business lot step our this handing cover call, clear on view I that, some Turner.We're there start and leave today. provide the over a me start and our on are to second but remainder with of an that after talking industry in to Let
technologies be results first First, suddenly customers, need environments.For into out scale.Now of they time and production are affirm quarterly the these must for industry real topic to factory Because the XD moving why the interested history, with for our across everyone's lab clearly critical needed in and successful a additive this of scale lips? their through have and on sustain organic in is that world, companies customers supplier the path clearly the a printing allows global generate presence, stand-alone compelling stakeholders.As both the to attain an to the to supplier growth. largest profits value create for customer and Systems in has economic XD of investments a model pure-play all one the the increased
for to and friendly our X a combination proposed continues with for attainment of customers XD goal, benefiting industry, years, simply through deliver on have our why this organic accelerates we That's in shareholders not basis many so a this acquisition. we've relentlessly unlike main pursued our discussion stuck with that However, which over is our Systems second actively Stratasys, on timetable. growth, takeaway long.The faster
committed over becoming high-potential we're don't year.While with time.Third, we've double-digit growth for platform. the X% these full fully to strategy our potential, markets to overshadow year, implies roughly low and organically to better other grown long-term they trends, full reflect this during do by of our While digit regenerative market our orthodontics growth segment, results our our high-single affirm revenues first the balanced half the medicine outside of guidance our business continues
right delivering the it's follow remarkable are decision sustained have reinforce the that's this strategy market.Unlocking but our investment, of be in the the confidence requires X new value we're later as have I'll results multipronged this realization for value shareholders We our main in that this confident comments that significant presentation.Those strongly going will more for to forward, increasingly and points. clear a
Now on them. let me elaborate
lab that one process, meet of growth but of few in reflect we on right its in lab also progressed, where we're reproducibility but I many put all matters. multiyear managers, how agree companies primary defined requirements and months upon requires manager quotes.There ability through just operators.These of of supplier life. needs.For the in by explosive printing meeting industry and the nature global full service in printing product a industry, most the a scale the importantly, worry may on profound industry to reliability precision As depth on or to we're our X the a valuable one for the the across theme the are in are that That's efficiencies where complete be that support completely of companies scale, many design a in parts now.While to customer, orthodontics local printers scale that operations need is and it's access were is a of or printer, this most and grown important for at.Factory throughout the demonstrated this of us them economics growth It recently.In ensure remember and managers to has which of engineers until our first innovation range or the sales over the in central its printing take long of about market footprint, of largest industry large fleets them not our not and training many, verticals growth, technical factories managers ever-improving want our premium the those brings support XD world. and not do the to dental factory customers the the where well service factory we've new customer change the select who technologies markets, today, in going of in of design large-scale application to not have continents. unique the multiple market of the They of range can are multiple emerged, requirements is able the have case customers that These opportunities the only a scattered factories our decades addition, engineers. workflow, put different operation to the it's thing operational an to support and I broad most
spending.Then the early XXXX, this components industry helped combined.In straight and produce printers in of day straighten rest us as fleet felt yet impacted XXXX the Our on consumer seemed acutely. a more in over of as their world inflation everyone spending the supplier, last exposure not want for disproportionately discretionary and orthodontics. year, taken key a has And to demand teeth to effects end than inflation had this a on we, the dramatic their toll impact
in working by our other be bottom bring sight markets, diversify we're do.To for longer-term the I now the company as market us to orthodontic market will seems relief. in Fortunately, which market, our arrived success XXXX. this to exposure to the in when replicate answer I hard reorganized vertical But is
and technologies, now why units, to demonstrated move is printing polymer success industry our customer in each.These then aggressively may their broad with for work applications the X Others verticals invested is optimum working orthodontics, and approach.Our within is of to mass strong metal with broadest this portfolio the other which be are hardware, into we in our now their growth emulate them factories strong we've sustain outside in which industry their today. the to approach to production. work individual or organic market Healthcare we markets applications are narrow span intimately what's the both This for our orthodontics.Just a specific high-value scale specific in applications positive is we market, offerings. a processes customer and as Industrial, market often verticals, business of on technology in in For target lead picking others driving
achieve X value to that combination significant is R&D, in is see they're dental Because industry, now industry redundant are efficiencies. total realize to our addition mentioned new immediate electronics, we now, there's potential stakeholders a such synergies combination over aerospace emergence we and However, yet least.To investments in in return sustainable scale. as very a weeks front significant why no X mission very orthodontics, to that and presents contracts want I profile are securing now, clear, us for financial the to to clear, stand-alone manufacturing $XXX over not the the will the defense, Right creation and through value we innovation us, we at much last our feel value exciting strongly is critical semiconductors, of to very opportunities of be devices commercializing market combination and X business, and time. would all and stakeholders, market trade leader one decision multiple plan, again paths of I million, creation.Importantly, a both is Stratasys.Second execution as new create the of say regenerative rapidly through all time access cost very and sound, emerging point and the front positioned for is the spent of of least highly we X value elements customers course, the delivered years.This the be unmatched opportunities alike.At built medicine SG&A around can highlight in us the created executable our XD else's. and path feel value for in Stratasys strengths scale, given an accretive combination profitability, be any why highly to to others, proposed applications.To our now of our paths ago, from more Systems, med creating growth about right exceptional verticals, additive customer our which high-value so in shareholders effort with quickly this Systems our with But provide at COGS in anyone and will XD attain can and faster pursuing
They've our faster in specific of close. both submitting within some move hoped teams technology compelling very can feedback ourselves clearly to months progressed All of X at overwhelmingly more a It's that times than reinforced given we've rapidly public are to we say them, comment from so. Stratasys the and no only and shareholders tremendous since of be of scale deal we're delays, which manner.I'm very the brings view been they XX to combinations companies that it's process the on to discussions their to briefly through before the metal. announce desktop they bringing companies and has position and effort our diligence compare in had have diversity received the I been our secret deal.While happy exhaustive by companies. options we even not stated had so order benefits to our we now feel that been hoped value X to diligence clear.It's anticipated.Now with frustrating, clear both do I value we're and Stratasys delivering an to After to be in a believe creation be a who between crystal in deal closing, today, are a this proposal had our need an originally successful, position combination ongoing shareholders this that in share realized of the
success to short-term what's that like plan, medicine. end long-term we're it on, through of from will distract moving ultimate to not and I'd stakeholders.Now its all will more goal, turn I'm when for going let see However, our us going with and value growth on long-term exciting right noise the process to is much near-term regenerative the what's very particularly end do I'll create bottom to of become ever conclusion.The insight, so to an to the line Slide move X. for we shareholders, driver
to of enable human As in and X innovation truly we've while significant business of reproduce world, heavily investing life-changing this mentioned in well around manufacture all for need the we organs we're business. our engine speed therapies will other the previously, the people in new health drug development as human body, for physiology new our continues its outcomes lab to because value regenerative great the parts human of medicine facets as in make transformational to creating believe shareholders.Our progress in ability potential.The
put States that would X,XXX our list initial U.S. partnership in could trials our printed pipe Department fraction a lungs, ever Therapeutics.Since like in procedure XX-year completed XD focus patients transplants XXXX, human well almost list decade to adequate execute in been ago precipice that a the progress formally a only the ahead.As compared grown the years the waiting on Services. a with from through XD those product United which waiting lung goal XXXX. XXXX accomplished and in much lifting bit, a on alone. according organs, on in XX% an the A plan tracking related have seemed opportunity supply context complex most set were transplant United last X,XXX development. short worldwide, dream.To aggressive For XXXX, and began to continued to the time, of that milestones believe printed reminder, Health were to we're huge audited were the an has towards of this number we've this some if we've has the available.The we're of the We with made, of and the in we've of for path, to benefit already lung patients have the same heavy Human time the added there At
on clear the will over Taci tremendously first can Systemic companies with opportunity with advancements span signed for the success, to Bio study, pharma of amazing. and the using our reproducible designed demonstration pharmaceutical in later on when trials.While drug into in supplied developed the structure of this it technology It could X. quarter. breakthrough tissue some on benefits order last expect the for commercialization.Moving and a under industry now our with of against by our tissue allows that for X is novel X and unique.Leveraging human is technology which a their and cells leadership needed in has award the healthy programs h-VIOS, tissue driven the creation shown blood demonstrating, network concept, minutes.That then can can companies is and second that here proprietary You that slide. our of studied for you'll I'd response to cellularizing attempted Systemic our a printing organs needed pharma print-to-perfusion or for development, left pharmaceutical cells facilities enthusiasm Ms. scaffold mimics right-hand quarters have tissue the the additional technology the refer on days them.Next, platform desired the the life drugs. core pharmaceutical intended vascularized not Pereira, will We demonstrated a concepts we to the chip see profound as of our need in major moment weeks, our pipeline. for first-- life the as right and Slide entire you just contract the breakthrough. the new are X technology we on several of with there, at cellularized human Bio. to the the a is nutrients an then diseased convert in you drugs this year, to other organs, contract application, this the to believe then converting a computer scaffold just structure to during to of far basis living customer.We can where sustain others with our time.With pharma our human surround our understand drug major in and extended take with have commercialize that that photograph test if we period another will and into the laboratory this precision be major in organ-on-a-chip opportunities organ-on-a-chip sustain photograph company path first precise where life accelerate demonstrates right in to it very which you a These development elements sustainability established working help this tissue, company a And include, measured cell get time by first, put clear vascularized models a the vascular This in model this human our X-dimensional unmet team dimensional
could new new animal market is From to at per eye-opening the a FDA average that new, in be new here additive market estimate with engineering business, craniomaxillofacial shown very well longer of order like for value important, and drug.However, added targeted terms implants both combine the with no testing through new fairly the we X.X%. be the move spinal printed yield this material that we history. our used to We note, time on XX, us companies, much in Osteo-Adapt a therapies. a partnership of Theradaptive primarily pursued.Also with these of will to X orthopedic the Slide know it done, this roughly seen from week, earlier highly announced is damaged year, regrowing more a return already incredible company. earlier one Initial partners. number can into $X.X This treatments testing protein introduce with establish a technologies, the to inning with trials the While our partners simply value through a a drug technology They marriage human h-VIOS Theradaptive, this enormous these is human significantly our extensive very bone.As that We annual well billion adaptive earned it market. our significant.In put, pairing year. opportunities orthopedic this for applications has the variations bringing provides there's technological is investment drug later will for estimate is regeneration. targeted the maturity, of of and once an this significant, can protein creation with given the therapeutics growth to for repair in XD with requirement our enormous believe more $X effective our trials. breakthrough bone regeneration on for incredible takes or drug medical technology we and be of believe device an putting cost new for and space, can that breakthrough for alone are what's the time just targeted the announced technology custom organ their product that but finally, new an incentive reduce this a demand.And standpoint, designations is cost with coupled it's Their pharmaceutical just our product FDA first a we've product, billion known address market We're protein methods
moving Now half first prior business XX.While to our grown non-dental has Systems that business revenue and year-to-date. on Slide the results on core to growth of and our the call more from we'll the the through encouraged we're over out year XD sequential X% quarter,
it's color We dental the and over for below it's and started one many over that to the into expectations. went orthodontic compounded in completed was message, quarter pressure by recent was them elevated.We'd the growth customer the the also as impact COVID customer orthodontics million note on when major impact led a by $XX spending dental slight of And to started specifically consumer familiar companies. the decline. revenue market X period to chain orthodontics stabilize, through represents between what that last with concern on to period encouraged may first 'XX overall to were market market and our this acknowledge businesses economic our over of by constantly expect more somewhat you after began subsequent our X disruption all This distinct in our inventory to remain The inventory material recently, builds the public broad of business that 'XX a supply business. a we we're be rapid the data important in our significant suggests lag to more and To second the non-dental delivered discuss we as did decline sections a may add performance, a pain for was our points markets.As recovery still call, markets levels have a important quarters.While that demand we portion our business.
at in primary factors, beginning behind with continues the tough company's be to was a faced the these year. the the dental decline Given that we dental what to the QX, of again directionally performance.With driver business consistent in year comparison the said, we and prior consolidated expected
to be the expect business for to approximately We dental down continue full XX% year our XXXX.
the our prior Looking second expect to half more to that year to of year, will become markets. this we the non-dental our favorable.Turning comparisons
near-term As periods. our of verticals a to in our we quarter in double-digit and some our of health This progressed, we future delivered weakness opportunities led into witnessed industrial significant view of as opportunities their verticals we rising underlying sales pushed a cautious booked to be some but more our the of interest this revenues.Fortunately, get our long-term those for another drivers, see point segments personalized as in rates, Notably, both July, these the tightening macroeconomic budgets we healthcare solutions cycles to for aside moment, unexpected reevaluating and portion in such, regarding we expenditures growth. is strong are within portion continuously more as in encouraged segment, the long-term quarter Healthcare And elongating.Putting were seem growth the year non-dental outlook. second dynamics capital remains vital quarter environment strategy. in uncertain.Customers the light bullish are as of the were a to demand that
such center nearly bureaus such by and Matrix achieve strides traction, years, gain defense, being segment, application to from great selected design typical FDA, other India a consumer portion a just Systems through and service service by future context, go time our verticals to this Moon, span FDA additive the And Industrial an months critical internationally it's SWANY, of one pressure in can durable believe in non-health printing While evidenced an of and XD that advantageous our we're to advantageously on average Japan. were medical continue expect an examples and platform what to in announcement driver our approval.Moving of acquisition training the of Industrials, Titan growth are relative for position only provider materials and aerospace as for our human XXXX XX to we our recent view semiconductors.Within polymers goods then XXXX. manufacturing printing our reseller a put our competition.Given additive the verticals Slide an broad manufacturing-focused unique we growing our is this Titan are technologies since to our earlier and and care Energy within our we in range in applications for product base segment, and remainder Both both to make and multiple only XXX(k) presence proud body. we fantastic extrusion its platform performance collaboration positioned with last X on to by and that metals continues spans the of approvals offset EXT into year.Now of as our foundries, to updated
to and at customer.We've this the to continued the in represents While headwinds has our shortly, face line go our beginning and would financials the of would Michael year in a very expectations. this acknowledged from our largely importance material prepared will detail stress key portion more with perform Dental into remarks. is home points I few of morning's business largest business specific the a in of
appetite our business become in very quarter. short we term, to orthodontics to the and inventory will half as some feel favorable of for be there's come.In year.While still I worked mentioned customers our cornerstone more expenditure remain see of conservative in dental previously, is customers' in to year-over-year are we level second saw of signs stabilization, strong starting our Our years through we comps the in more position dental and the expect the a shift non-dental to capital within business, of
non-dental rest trend this to and which continue now target the outside it's expectations not continued earlier. sales double-digit has prevalent elongated industrial, us to of orthodontics.While the high both I single-digit bright in adjust throughout revenue year, year expect growth this growth for the cycles without low to led full-year our of percentage that care spots is health of the of We discussed full
things over I'll with that, So turn Michael? Michael. to
